Life Science


In the last 25 years, the lifescience sector has been a leader (with a market share of around 15%), thanks to the recognized quality of the product and the technologies used that have allowed it to establish itself on extremely strict and controlled markets such as the American, European and Japanese.

See more on Point of View – Nanotechnolgies

See more on Point of View – Biotech

Competitive Advantage

  • 1st Country by number of Advanced Therapy products authorized by the EU (3 out of 5)
  • Worldwide medtech sales are forecast to grow at an annual compound growth rate of 5.1 percent, reaching US$521.9 billion by 2022.